share_log

Navidea Biopharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Moss Dana J

SEC ·  Nov 21, 2023 07:43
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more